VBCFacilities
WELCOME TO THE VIENNA BIOCENTER CORE FACILITIES

Access to state-of-the-art research infrastructure and scientific services.

Contact us!
WELCOME TO THE VIENNA BIOCENTER CORE FACILITIES

Access to state-of-the-art research infrastructure and scientific services.

Contact us!
WELCOME TO THE VIENNA BIOCENTER CORE FACILITIES

Access to state-of-the-art research infrastructure and scientific services.

Contact us!

We enable scientists to achieve their goals by providing access to cutting-edge research infrastructure in the field of biomedical research.

We keep our resources, technology, and expertise at the highest level in order to stay at the forefront of science.

The Vienna Biocenter Core Facilities (VBCF) have been publicly funded by the Austrian Federal Ministry of Education, Science and Research, and the City of Vienna via Vienna Business Agency.

Our shareholders are Vienna BioCenter, MPL, IMBA, University of Vienna, and GMI.

Shareholders
Link to Page
Link to Page
Link to Page
Link to Page
Link to Page
Funding Bodies
Link to Page
Link to PageCiry of Vienna

Facilities

Advanced MIcroscopy
ADVANCED MICROSCOPY
Electron Microscopy
ELECTRON MICROSCOPY
HistoPathology
HISTOPATHOLOGY
MASS SPECTROMETRY

Metabolomics
METABOLOMICS
Next generation sequencing
NEXT GENERATION SEQUENCING
Plant Sciences
PLANT SCIENCES
Preclinical Phenotyping
PRECLINICAL PHENOTYPING

Protein Technologies
PROTEIN TECHNOLOGIES
SARS-CoV2 Screening
SARS-COV2 SCREENING
Vienna Drosophila Resource Center
VIENNA DROSOPHILA RESOURCE CENTER
Kindergarden
CHILD CARE CENTER

ACCESS FOR FACILITIES' USERS

MyVBCF

WE BRING YOU NEW KNOWLEDGE - TAKE ADVANTAGE OF IT!

See VBCF Events & Trainings

Network

Link to Page
Link to Page
Link to Page
Link to Page
Link to Page
Link to Page

PROJECT & GRANTS

See VBCF Projects & Grants
VBCF team

Downloads

Selected publications

Identification of ALK in Thinness
Orthofer M, Valsesia A, Mägi R, Wang QP, Kaczanowska J, Kozieradzki I, Leopoldi A, Cikes D, Zopf LM, Tretiakov EO, Demetz E, Hilbe R, Boehm A, Ticevic M, Nõukas M, Jais A, Spirk K, Clark T, Amann S, Lepamets M, Neumayr C, Arnold C, Dou Z, Kuhn V, et al.
2020, Cell. 2020 May 21:S0092-8674(20)30497-9.
CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci
Chylinski K, Hubmann M, Hanna RE, Yanchus C, Michlits G, Uijttewaal ECH, Doench J, Schramek D & Elling U
2019, Nature Communications volume 10
Molecular features of the UNC-45 chaperone critical for binding and folding muscle myosin
Hellerschmied D, Lehner A, Franicevic N, Arnese R, Johnson C, Vogel A, Meinhart A, Kurzbauer R, Deszcz L, Gazda L, Geeves M & Clausen T
2019, Nature Communications volume 10
Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells
Bönelt P, Wöhner M, Minnich M, Tagoh H, Fischer M, Jaritz M, Kavirayani A, Garimella M, Karlsson MCI, Busslinger M
2019, EMBO J. 2019 Jan; 38(2)
AIF-regulated oxidative phosphorylation supports lung cancer development
Rao S, Mondragón L, Pranjic B, Hanada T, Stoll G, Köcher T, Zhang P, Jais A, Lercher A, Bergthaler A, Schramek D, Haigh K, Sica V, Leduc M, Modjtahedi N, Pai TP, Onji M, Uribesalgo I, Hanada R, Kozieradzki I, Koglgruber R, Cronin SJ, She Z, Quehenberger F
2019, Cell Res. 2019 Jul

Management

Dr Daniele Soroldoni
Managing Director
VBC2 / PG7

RESEARCH INFRASTRUCTURES – A KEY INSTRUMENT IN ADVANCEMENT OF KNOWLEDGE AND TECHNOLOGY

More

Contact

VBCF, Dr. Bohr Gasse 3, 1030 Vienna, Austria
contact@vbcf.ac.at, +43 1 796 23 24 7000